|
Duloxetine Versus Placebo in Patients With Major Depressive Disorder (MDD): Assessment of Energy and Vitality in MDD |
Duloxetine hydrochloride |
F1J-US-HMFS |
NCT00536471 |
Major Depressive Disorder |
Phase 4 |
|
|
Not available |
|
The annotated case report form is not available. A blank case report form will be provided. |
July 2014 |